Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Qianpeng ^a   Wu, Yanqiu ^a   Wang, Jing ^a   Wu, Guojun ^a   Long, Wenmin ^a   Xue, Zhengsheng ^a   Wang, Linghua ^a   Zhang, Xiaojun ^a   Pang, Xiaoyan ^a   Zhao, Yufeng ^b   Zhao, Liping ^a,b   Zhang, Chenhong ^a  

^a Shanghai Jiao Tong University   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; DEXTRAN SULFATE;

ADULT; ANIMAL; BACTERIAL GENOME; C57BL MOUSE; CHEMICALLY INDUCED; CLOSTRIDIALES; COLITIS; COLON; DISEASE MODEL; DYSBIOSIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HIGH THROUGHPUT SEQUENCING; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; INTESTINE FLORA; MALE; METABOLISM; MICROBIOLOGY; MOUSE; ORGANISMAL INTERACTION; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

ADULT; ANIMALS; BUTYRIC ACID; CLOSTRIDIALES; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; GENOME, BACTERIAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICROBIAL INTERACTIONS;

EID: 84973342043     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27572     Document Type: Article

References (68)

1. Roediger, W. E. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21, 793-798 (1980).
2. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450 (2013).
3. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455 (2013).
4. Steliou, K., Boosalis, M. S., Perrine, S. P., Sangerman, J. & Faller, D. V. Butyrate histone deacetylase inhibitors. Biores Open Access 1, 192-198 (2012).
5. Scheppach, W. et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103, 51-56 (1992).
6. Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S. & Flint, H. J. The microbiology of butyrate formation in the human colon. FEMS microbiology letters 217, 133-139 (2002).
7. Willing, B. P. et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844-1854.e1841 (2010).
8. Pozuelo, M. et al. Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep 5, 12693 (2015).
9. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
10. Wang, T. et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. Isme j 6, 320-329 (2012).
11. Keshavarzian, A. et al. Colonic bacterial composition in Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society 30, 1351-1360 (2015).
12. Van Immerseel, F. et al. Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol 59, 141-143 (2010).
13. Marteau, P. Butyrate-producing bacteria as pharmabiotics for inflammatory bowel disease. Gut 62, 1673 (2013).
14. Podolsky, D. K. Inflammatory bowel disease. The New England journal of medicine 347, 417-429 (2002).
15. Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298-306 (2011).
16. Manichanh, C., Borruel, N., Casellas, F. & Guarner, F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9, 599-608 (2012).
17. Sokol, H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15, 1183-1189 (2009).
18. Machiels, K. et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275-1283 (2014).
19. Kang, S. et al. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis 16, 2034-2042 (2010).
20. Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105, 16731-16736 (2008).
21. Eeckhaut, V., Ducatelle, R., Sas, B., Vermeire, S. & Van Immerseel, F. Progress towards butyrate-producing pharmabiotics: Butyricicoccus pullicaecorum capsule and efficacy in TNBS models in comparison with therapeutics. Gut 63, 367 (2014).
22. Okamoto, T. et al. Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats. J Gastroenterol 35, 341-346 (2000).
23. Kanauchi, O. et al. Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J Gastroenterol 12, 1071-1077 (2006).
24. Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S. & Flint, H. J. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217, 133-139 (2002).
25. Louis, P., Young, P., Holtrop, G. & Flint, H. J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 12, 304-314 (2010).
26. Vital, M., Howe, A. C. & Tiedje, J. M. Revealing the bacterial butyrate synthesis pathways by analyzing (meta) genomic data. MBio 5, e00889 (2014).
27. Duncan, S. H., Barcenilla, A., Stewart, C. S., Pryde, S. E. & Flint, H. J. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 68, 5186-5190 (2002).
28. Allen-Vercoe, E. et al. Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. Anaerobe 18, 523-529 (2012).
29. Chen, L., Xiong, Z., Sun, L., Yang, J. & Jin, Q. VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res 40, D641-645 (2012).
30. Cahill, R. J. et al. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 65, 3126-3131 (1997).
31. Hudcovic, T., Stepankova, R., Cebra, J. & Tlaskalova-Hogenova, H. The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol (Praha) 46, 565-572 (2001).
32. Heimesaat, M. M. et al. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One 2, e662 (2007).
33. Schwab, C. & Berry, D. Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. Isme j 8, 1101-1114 (2014).
34. Berry, D. et al. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. Isme j 6, 2091-2106 (2012).
35. Costello, E. K., Stagaman, K., Dethlefsen, L., Bohannan, B. J. & Relman, D. A. The application of ecological theory toward an understanding of the human microbiome. Science 336, 1255-1262 (2012).
36. Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110, 9066-9071 (2013).
37. Derrien, M., Collado, M. C., Ben-Amor, K., Salminen, S. & de Vos, W. M. The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol 74, 1646-1648 (2008).
38. Derrien, M. et al. Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front Microbiol 2, 166 (2011).
39. Shin, N. R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727-735 (2014).
40. Hakansson, A. et al. Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clinical and experimental medicine 15, 107-120 (2015).
41. Reikvam, D. H. et al. Epithelial-microbial crosstalk in polymeric Ig receptor deficient mice. European journal of immunology 42, 2959-2970 (2012).
42. Weir, T. L. et al. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 8, e70803 (2013).
43. Liu, J. et al. Acute cholecystitis associated with infection of Enterobacteriaceae from gut microbiota. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 21, 851.e851-859 (2015).
44. Ganesh, B. P., Klopfleisch, R., Loh, G. & Blaut, M. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One 8, e74963 (2013).
45. Lange, S., Delbro, D. S., Jennische, E. & Mattsby-Baltzer, I. The role of the Lps gene in experimental ulcerative colitis in mice. Apmis 104, 823-833 (1996).
46. Nagai, F., Morotomi, M., Sakon, H. & Tanaka, R. Parasutterella excrementihominis gen. nov., sp. nov., a member of the family Alcaligenaceae isolated from human faeces. Int J Syst Evol Microbiol 59, 1793-1797 (2009).
47. Hu, J., Franzen, O., Pei, Z., Itzkowitz, S. & Peter, I. P-237 Multiple Double-barcoding 16S Sequencing on the MiSeq Platform to Study the Gut Microbiome in Ashkenazi Jews with Crohn's Disease. Inflammatory Bowel Diseases 19, S119-S121 (2013).
48. Boyle, R. J., Robins-Browne, R. M. & Tang, M. L. Probiotic use in clinical practice: what are the risks? The American journal of clinical nutrition 83, 1256-1264 (2006).
49. Farina, C., Arosio, M., Mangia, M. & Moioli, F. Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis. J Clin Gastroenterol 33, 251-252 (2001).
50. Kunz, A. N., Noel, J. M. & Fairchok, M. P. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 38, 457-458 (2004).
51. Cannon, J. P., Lee, T. A., Bolanos, J. T. & Danziger, L. H. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology 24, 31-40 (2005).
52. Besselink, M. G. et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371, 651-659 (2008).
53. Barcenilla, A. et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66, 1654-1661 (2000).
54. Zhang, X. et al. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One 7, e42529 (2012).
55. Chin, C. S. et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 10, 563-569 (2013).
56. Delcher, A. L., Bratke, K. A., Powers, E. C. & Salzberg, S. L. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23, 673-679 (2007).
57. Xu, Z. & Hao, B. CVTree update: a newly designed phylogenetic study platform using composition vectors and whole genomes. Nucleic Acids Res 37, W174-178 (2009).
58. Nishihara, T. et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131, 853-861 (2006).
59. Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286 (2009).
60. Godon, J. J., Zumstein, E., Dabert, P., Habouzit, F. & Moletta, R. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 63, 2802-2813 (1997).
61. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
62. Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10, 996-998 (2013).
63. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200 (2011).
64. Cole, J. R. et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res 42, D633-642 (2014).
65. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335-336 (2010).
66. Breiman, L. Random forests. Machine learning 45, 5-32 (2001).
67. Friedman, J. & Alm, E. J. Inferring correlation networks from genomic survey data. PLoS Comput Biol 8, e1002687 (2012).
68. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological) 58, 289-300 (1995).